Latest Transformation News

Yojee Limited reports a robust cash reserve and significant progress in its MOSAIC platform beta testing, alongside new customer contracts and strategic leadership hires, setting the stage for its 2026 commercial rollout.

Centaurus Metals has achieved a key milestone with the granting of the Jaguar Nickel Sulphide Project mining lease and bolstered its copper-gold portfolio through the acquisition of the Rio Novo tenure, setting the stage for accelerated development and exploration in Brazil’s Carajás Mineral Province.

ASX Limited has updated its FY26 expense growth guidance upwards, reflecting increased investments in risk management and technology modernisation alongside ASIC Inquiry-related costs, while reporting strong unaudited 1H26 revenue growth.

Imricor Medical Systems has achieved multiple world-first procedures using real-time MRI guidance for cardiac ablation, advancing clinical trials and regulatory progress amid a strategic commercial expansion.

AUB Group has successfully raised AUD 400 million through an institutional placement to fund its acquisition of Prestige and support future growth. A complementary AUD 40 million Share Purchase Plan will also be offered to eligible shareholders.

Epiminder Limited has successfully listed on the ASX, raising $125 million to commercialise its FDA-approved Minder device. The company has initiated the first US implant and secured five leading medical centres for its DETECT study.

Algorae Pharmaceuticals has advanced its AI drug discovery capabilities with the launch of AlgoraeOS v2 and secured key commercial partnerships, including a $3 million debt facility to support expansion in Australia and New Zealand.

Greatland Resources capped off 2025 with robust gold and copper production at Telfer, generating $406 million in operating cash flow, while its Havieron feasibility study confirmed a world-class, low-cost gold-copper mine with a $4.2 billion pre-tax NPV.

LTR Pharma has marked a key milestone with over 1,000 SPONTAN prescriptions under Australia’s Special Access Scheme and is advancing clinical trials and US market preparations for its erectile dysfunction treatments.

Ore Resources Ltd has reported significant high-grade gold intercepts at its Miriam Project, extending mineralisation at Forrest to 850 metres. The company also secured binding options to acquire the Randalls Gold Project and raised A$7.5 million to fund its ambitious 2026 exploration plans.

Mitchell Services Limited has reported a remarkable first half of FY26, posting a 71% increase in quarterly EBITDA and achieving a net cash position of $7.2 million. The company’s strong operating cashflows and improved market conditions underpin its optimistic outlook.

Argenica Therapeutics has unveiled compelling AI-driven results confirming ARG-007’s significant benefits in severe acute ischemic stroke patients, setting the stage for a precision-focused Phase 2b trial.